Esteban Lopez

Israel Operations of Tikun Olam Up for Sale

Israeli cannabis company Tikun Olam has decided to sell its Israel-based operations; the company’s international holdings in the U.S., Canada, Australia, and Greece, however, are not for sale.

Full story after the jump.

Medical cannabis company Tikun Olam is reportedly looking to sell their operations in Israel following a Health Ministry decision to revoke the firm’s license unless founder and controlling shareholder Yitzhak (Tzahi) Cohen cut back on his holdings, the Times of Israel reports. Tikun was the first company to receive a medical cannabis license in Israel and is its largest industry operator.

The company’s operations include a 0.74-acre cannabis farm; a Nazareth Illit factory that is under construction; offices and a clinic in Tel Aviv; and an 8,000-person patient list – altogether worth about $100 million.

Cohen has a 70 percent stake in the company and the Health Ministry had ordered him to whittle that figure down to about 5 percent or lose his license. Law enforcement had also recommended to the ministry that the company’s cultivation license not be renewed, and Cohen end his activities in the space. Last year, the Health Ministry ordered the company to temporarily stop work over concerns that its drying process was not in line with regulations.

Aharon Lutzky, president of Tikun Olam said the company would “act in accordance with the court’s directive.”

“… Our goal is to ensure that our patients are able to continue receiving the treatment they are waiting for when the company returns to full activity in Israel – regardless of its ownership structure.” – Lutzky, to the Calcalist, via the Times

The company also has operations in the U.S., Canada, Australia, and Greece. Those divisions are not up for sale.

Get daily cannabis business news updates. Subscribe

Have an additional perspective to share? Send us a message to let us know, and if your comment is chosen by our editors it could be featured here.

End


Latest Cannabis News

View all news Get email updates

Featured Business Profiles

Create a profile View all categories

From Our Partners